Fan Yu-Hua, Chang Yen-Hwa, Huang William J S, Chung Hsiao-Jen, Chen Kuang-Kuo
Division of Urology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
J Chin Med Assoc. 2008 May;71(5):254-8. doi: 10.1016/S1726-4901(08)70116-3.
Renal oncocytoma has been reported mostly in the Western literature, and only a few cases have been reported in Eastern populations. In the present study, we review the clinical course of renal oncocytoma in our institution.
We obtained the files of 13 cases of renal oncocytoma between 1988 and 2006 from the pathological archives of Taipei Veterans General Hospital. We retrospectively analyzed the patients' characteristics, clinical manifestations, surgical technique and clinical outcome.
The study population comprised 10 men and 3 women, and the mean age at diagnosis was 59.6 years (range, 37-75 years). Twelve patients (92%) were asymptomatic at presentation and were incidentally diagnosed to have renal tumor by sonography (9 patients), computed tomography (1 patient) or magnetic resonance imaging (2 patients), and 1 presented with hematuria. The clinical impression of oncocytoma was made preoperatively in only 3 patients by imaging studies, and most of the patients (76.9%) were diagnosed with renal cell carcinoma before surgery. Ten were treated with radical nephrectomy, 2 with partial nephrectomy, and 1 received excisional biopsy. All patients had unilateral solitary renal tumor; the right kidney was involved in 7 cases (54%) and the left in 6 (46%). Mean tumor size was 5.3 cm (range, 2.7-8.5 cm). Three patients were lost to follow-up in our series, and there was no recurrence or death (100% disease-specific survival) in the remaining 10 patients (77%) who were followed-up for a mean duration of 53.2 months (range, 10-117 months).
Renal oncocytoma has a benign clinical course with excellent long-term outcomes. Currently, nephron-sparing surgery is the mainstay of treatment, especially in patients with small tumors. However, accurate preoperative diagnosis based only on imaging studies is difficult, and radical nephrectomy was performed for most of the patients in our series.
肾嗜酸细胞瘤大多在西方文献中有报道,而在东方人群中仅有少数病例报道。在本研究中,我们回顾了我院肾嗜酸细胞瘤的临床病程。
我们从台北荣民总医院病理档案中获取了1988年至2006年间13例肾嗜酸细胞瘤病例资料。我们回顾性分析了患者的特征、临床表现、手术技术及临床结局。
研究人群包括10名男性和3名女性,诊断时的平均年龄为59.6岁(范围37 - 75岁)。12例患者(92%)就诊时无症状,通过超声检查(9例)、计算机断层扫描(1例)或磁共振成像(2例)偶然诊断为肾肿瘤,1例表现为血尿。术前仅3例患者通过影像学检查临床诊断为嗜酸细胞瘤,大多数患者(76.9%)在手术前被诊断为肾细胞癌。10例行根治性肾切除术,2例行部分肾切除术,1例行切除活检。所有患者均为单侧孤立性肾肿瘤;右肾受累7例(54%),左肾受累6例(46%)。平均肿瘤大小为5.3 cm(范围2.7 - 8.5 cm)。本系列中有3例患者失访,其余10例患者(77%)平均随访53.2个月(范围10 - 117个月),无复发或死亡(疾病特异性生存率100%)。
肾嗜酸细胞瘤临床病程良性,长期预后良好。目前,保留肾单位手术是主要治疗方法,尤其是对于小肿瘤患者。然而,仅基于影像学检查进行准确的术前诊断困难,本系列中大多数患者接受了根治性肾切除术。